About VIB (87)
Bio imaging core (1)
Business opportunities (12)
Cardiovascular medicine (16)
Cell biology (11)
Developmental biology (4)
Inflammation and immunity (30)
International PhD Program (1)
Plant biology (84)
Structural biology (16)
Systems biology (7)
Page Content Zone 1
New discoveries place lack of energy at the basis of Parkinson’s Disease
20 March 2014
Neuroscientists Vanessa Moraïs and Bart De Strooper from VIB and KU Leuven have demonstrated how a defect in the gene Pink1 results in Parkinson’s disease.
Our brain has switch board to guide behavior in response to external stimuli
14 February 2014
NERF-scientists demonstrate that the habenula, a specific part in our brain consisting of neural circuits, acts as a gate for sensory information, thus regulating behavior in response to external stimuli.
New technology for the detection of genetic abnormalities which lead to serious epilepsy
22 January 2014
An international consortium including researchers from VIB, the University of Antwerp and KU Leuven demonstrates that defects in the CHD2 gene lead to Dravet Syndrome, a serious form of epilepsy.
Finding the genetic causes of spinal muscular atrophy
23 September 2013
Kristien Peeters and Albena Jordanova (VIB-UA), have identified BICD2 mutations as a cause of spinal muscular atrophy (SMA). Their findings have important implications for future diagnostic tests.
Brain dysfunctions: shared mechanisms in fragile X syndrome, autism and schizophrenia at neuronal synapses
18 September 2013
Several psychiatric conditions share the same brain cell abnormalities. Claudia Bagni and her group have unraveled how a single protein orchestrates two biological processes to form proper contacts between brain cells.
Fragile X syndrome protein linked to breast cancer progression
18 September 2013
Claudia Bagni (VIB/KU Leuven, Belgium, and the University of Rome Tor Vergata, Italy), has identified the way Fragile X Mental Retardation Protein or FMRP contributes to the progression of breast cancer.
The brain is the last great frontier - Joris de Wit
15 June 2013
“When I was fourteen, I already knew I wanted to be a scientist. I was fascinated with biology and how things work. The brain is the last great frontier,” says Joris de Wit.
Exploring the process of physiological brain aging
15 June 2013
Aging is a risk factor for several neurodegenerative diseases. Little is known about the process of physiological brain aging in the absence of neurodegeneration.
25-31 August, 2013 - RNA and the Etiology of Brain Disease - Cortona, Italy
5 June 2013
The IBRO-Kemali College on “RNA and the Etiology of Brain Disease” will be held at the Neuroscience School of Advanced Studies from August 25th until August 31st, 2013.
Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven join forces to combat neurological diseases
29 May 2013
Janssen and Johnson & Johnson Innovation are launching Stellar. This project will overcome the inefficiencies in translating basic molecular insights to diagnostics and therapeutics for neurodegenerative diseases.
A new strategy required in the search for Alzheimer's drugs?
24 May 2013
Alessia Soldano and Bassem Hassan (VIB/KU Leuven) were the first to unravel the function of APPL – the fruit-fly version of APP – in the brain of healthy fruit flies.
Faulty energy production in brain cells leads to disorders ranging from Parkinson’s to intellectual disability
16 May 2013
Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities.
Fruit flies can help us for the development of improved anesthetics
20 March 2013
General anesthetic result in a loss of consciousness and insensitivity to pain, apparently in the same manner in all animals, from invertebrates to humans.
Prevention is better than cure. Also for Alzheimer’s disease!
1 February 2013
On Monday 4 February, Dennis J. Selkoe and five other “brain teasers” will receive an honorary doctorate from the KU Leuven.
LRRK2 control of synapse - a delicate balancing exercise
14 December 2012
Until now, it was not clearly understood how LRRK2 regulated synaptic function necessary in the treatment of Parkinson’s. This situation has now been remedied by Samer Matta from the Bart De Strooper lab, in collaboration with the Patrik Verstreken lab.
Page Content Zone 2
Page Content Zone 3
Get news updates:
Follow us on Twitter
Like us on Facebook
Inflammation and immunity
Training and facilities
Int. Ph.D. Program